Structure, function and regulation of the melanocortin receptors
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Melanocortin receptors belong to the seven-transmembrane (TM) domain proteins that are coupled to G-proteins and signaled through intracellular cyclic adenosine monophosphate. Many structural features conserved in other G-protein coupled receptors (GPCRs) are found in the melanocortin receptors. There are five melanocortin receptor subtypes and each of the melanocortin receptor subtypes has a different pattern of tissue expression and has its own profile regarding the relative potency of different melanocortin peptides. α-, β-, and γ-MSH and ACTH are known endogenous agonist ligands for the melanocortin receptors. Agouti and AgRP are the only known naturally occurring antagonists of the melanocortin receptors. We have examined the molecular basis of all five human melanocortin receptors for different ligand binding affinity and potency using chimeric and mutated receptors. Our studies indicate that human melanocortin MC1 receptor, human melanocortin MC3 receptor, human melanocortin MC4 receptor and human melanocortin MC5 receptor utilize orthosteric sites for non selective agonists, α-MSH and NDP- β-MSH, high affinity binding and utilize allosteric sites for selective agonist or antagonist binding. Furthermore, our results indicate that molecular determinants of human melanocortin MC2 receptor for ACTH binding and signaling are different from that of other melanocortin receptors. Many studies also indicate that agonists can induce different conformation changes of melanocortin receptors, which then lead to the activation of different signaling pathways, even when the expression level of receptor and the strength of stimulus-response coupling are the same. This finding may provide new information for the design of drugs for targeting melanocortin receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030 · cited 1×
“The physiological significance of the melanocortin receptor family has promoted considerable research activity over past decade (Adan et al., 1997; Adan and Vink, 2001; Chen et al., 2000a; Chen et al., 2000b; Chen et al., 2007a; Huszar et al., 1997; Hwa et al., 2001).”
BackgroundThe cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635 · cited 2×
“…MC1 receptor, human melanocortin MC2 receptor, human melanocortin MC3 receptor, human melanocortin MC4 receptor, and human melanocortin MC5 receptor, have been cloned (Gantz et al., 1996; Gantz et al., 1993; Gantz et al., 1997; Gantz et al., 1994a; Gantz et al., 1994b; Mountjoy et al., 1992).”
BackgroundAnatomy and regulation of the central melanocortin system
Cone, R. D. (2005) · Nature Neuroscience · doi:10.1038/nn1455 · Cited by 1,583 · cited 1×
“Melanocortin MC5 receptor is expressed in numerous human peripheral tissues and is mainly involved in exocrine function, particularly sebaceous gland secretion discovered by targeted deletion of that receptor (Adan et al., 1999; Cone, 1999; 2005; Gantz and Fong, 2003).”
BackgroundInteractions of Human Melanocortin 4 Receptor with Nonpeptide and Peptide Agonists,
Pogozheva, I. D., Chai, B.-X., Lomize, A. L., Fong, T. M., Weinberg, D. H., Nargund, R. P., Mulholland, M. W., Gantz, I., & Mosberg, H. I. (2005) · Biochemistry · doi:10.1021/bi0501840 · Cited by 92 · cited 6×
“Mutation of these residues to alanine resulted in significantly decrease in endogenous agonist binding and receptor signaling, suggesting that these residues are also involved in melanocortin orthosteric binding (Fleck et al., 2005; Haskell-Luevano et al., 2001; Nickolls et al., 2003; Pogozheva et al., 2005; Yang et a…”
BackgroundInfluential
Research works printed but not linked: 40
- Adan, 2001, Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders, Eur. Neuropsychopharmacol., 11, 483, 10.1016/S0924-977X(01)00125-0 · DOI
- Adan, 1997, Molecular pharmacology of neural melanocortin receptors, Recept. Channels, 5, 215
- Adan, 1999, Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat, Eur. J. Pharmacol., 378, 249, 10.1016/S0014-2999(99)00465-3 · DOI
- Chai, 2006, Melanocortin-3 receptor activates MAP kinase via PI3 kinase, Regul. Pept.
- Chai, 2006, Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase, Peptides, 27, 2846, 10.1016/j.peptides.2006.05.005 · DOI
- Chai, 2009, Melanocortin-4 receptor activation inhibits c-Jun N-terminal kinase activity and promotes insulin signaling, Peptides, 30, 1098, 10.1016/j.peptides.2009.03.006 · DOI · Paper page
- Chen, 2000, Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass, Nat. Genet., 26, 97, 10.1038/79254 · DOI · Paper page
- Chen, 2000, Role of the melanocortin-4 receptor in metabolic rate and food intake in mice, Transgenic Res., 9, 145, 10.1023/A:1008983615045 · DOI · Paper page
- Chen, 2006, Molecular characterization of human melanocortin-3 receptor ligand–receptor interaction, Biochemistry, 45, 1128, 10.1021/bi0521792 · DOI
- Chen, 2007, Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexia, J. Med. Chem., 50, 5249, 10.1021/jm070806a · DOI
- Chen, 2007, Molecular identification of the human melanocortin-2 receptor responsible for ligand binding and signaling, Biochemistry, 46, 11389, 10.1021/bi700125e · DOI · Paper page
- Chen, 2007, Contribution of the conserved amino acids of the melanocortin-4 receptor in [corrected] [Nle4, D-Phe7]-alpha-melanocyte-stimulating [corrected] hormone binding and signaling, J. Biol. Chem., 282, 21712, 10.1074/jbc.M702285200 · DOI · Paper page
- Cone, 1999, The central melanocortin system and energy homeostasis, Trends Endocrinol. Metab., 10, 211, 10.1016/S1043-2760(99)00153-8 · DOI · Paper page
- Cone, 1996, The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation, Recent Prog. Horm. Res., 51, 287
- Fleck, 2005, Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor, Biochemistry, 44, 14494, 10.1021/bi051316s · DOI
- Fleck, 2007, Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation, Biochemistry, 46, 10473, 10.1021/bi700406k · doi:10.1021/bi700406k
- Gantz, 2003, The melanocortin system, Am. J. Physiol. Endocrinol. Metab., 284, E468, 10.1152/ajpendo.00434.2002 · DOI · Paper page
- Gantz, 1993, Molecular cloning, expression, and gene localization of a fourth melanocortin receptor, J. Biol. Chem., 268, 15174, 10.1016/S0021-9258(18)82452-8 · DOI · Paper page
- Gantz, 1994, Molecular cloning, expression, and characterization of a fifth melanocortin receptor, Biochem. Biophys. Res. Commun., 200, 1214, 10.1006/bbrc.1994.1580 · DOI · Paper page
- Gantz, 1994, Mapping of the gene encoding the melanocortin-1 (alpha-melanocyte stimulating hormone) receptor (MELANOCORIN MC1R) to human chromosome 16q24.3 by fluorescence in situ hybridization, Genomics, 19, 394, 10.1006/geno.1994.1080 · DOI
- Gantz, 1996, Molecular cloning of a novel receptor (CMKLR1) with homology to the chemotactic factor receptors, Cytogenet. Cell Genet., 74, 286, 10.1159/000134436 · DOI · Paper page
- Gantz, 1997, Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis, Genomics, 42, 462, 10.1006/geno.1997.4752 · DOI
- Haskell-Luevano, 1996, Three-dimensional molecular models of the hMELANOCORIN MC1R melanocortin receptor: complexes with melanotropin peptide agonists, Drug Des. Discov., 14, 197
- Haskell-Luevano, 2001, Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants, Biochemistry, 40, 6164, 10.1021/bi010025q · DOI · Paper page
- Hogan, 2006, Mapping the binding site of melanocortin 4 receptor agonists: a hydrophobic pocket formed by I3.28(125), I3.32(129), and I7.42(291) is critical for receptor activation, J. Med. Chem., 49, 911, 10.1021/jm050780s · DOI
- Holder, 2004, Melanocortin ligands: 30years of structure-activity relationship (SAR) studies, Med. Res. Rev., 24, 325, 10.1002/med.10064 · DOI
- Hwa, 2001, Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats, Am. J. Physiol. Regul. Integr. Comp. Physiol., 281, R444, 10.1152/ajpregu.2001.281.2.R444 · DOI · Paper page
- Nickolls, 2003, Molecular determinants of melanocortin 4 receptor ligand binding and MELANOCORIN MC4/MELANOCORIN MC3 receptor selectivity, J. Pharmacol. Exp. Ther., 304, 1217, 10.1124/jpet.102.044974 · DOI
- Oosterom, 2001, Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein, J. Biol. Chem., 276, 931, 10.1074/jbc.M007261200 · DOI
- Prusis, 1997, Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide, J. Mol. Graph. Model., 15, 334
- Sun, 2007, Molecular modeling of melanocortin receptors, Curr. Top. Med. Chem., 7, 1042, 10.2174/156802607780906573 · DOI
- Yang, 2003, Recent developments in our understanding of melanocortin system in the regulation of food intake, Obes. Rev., 4, 239, 10.1046/j.1467-789X.2003.00104.x · DOI
- Yang, 1997, Molecular basis for the interaction of [Nle4, D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor, J. Biol. Chem., 272, 23000, 10.1074/jbc.272.37.23000 · DOI · Paper page
- Yang, 1999, Contribution of melanocortin receptor exoloops to Agouti-related protein binding, J. Biol. Chem., 274, 14100, 10.1074/jbc.274.20.14100 · DOI
- Yang, 2000, Molecular determinants of ligand binding to the human melanocortin-4 receptor, Biochemistry, 39, 14900, 10.1021/bi001684q · DOI · Paper page
- Yang, 2002, Molecular determinants of human melanocortin-4 receptor responsible for antagonist SHU9119 selective activity, J. Biol. Chem., 277, 20328, 10.1074/jbc.M201343200 · DOI
- Yang, 2003, Molecular determination of agouti-related protein binding to human melanocortin-4 receptor, Mol. Pharmacol., 64, 94, 10.1124/mol.64.1.94 · DOI
- Yang, 2005, Molecular mechanism of the intracellular segments of the melanocortin-4 receptor for NDP-MSH signaling, Biochemistry, 44, 6971, 10.1021/bi047521+ · DOI
- Yang, 2007, Structural insights into the role of the ACTH receptor cysteine residues on receptor function, Am. J. Physiol. Regul. Integr. Comp. Physiol., 293, R1120, 10.1152/ajpregu.00240.2007 · DOI
- Yang, 2009, Key amino acid residues in the melanocortin-4 receptor for nonpeptide THIQ specific binding and signaling, Regul. Pept., 10.1016/j.regpep.2009.03.006 · DOI
Cited by
Oyola, M. G., & Handa, R. J. (2017) · Stress · doi:10.1080/10253890.2017.1369523 · Cited by 710
“There are five melanocortin receptor subtypes (MC1RMC5R), all of which have different expression patterns and specific functions (Yang, 2011).”
BackgroundThe Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens
Lim, B. K., Huang, K. W., Grueter, B. A., Rothwell, P. E., & Malenka, R. C. (2012) · Nature · doi:10.1038/nature11160 · Cited by 368
Melanocortin 1 Receptor: Structure, Function, and Regulation
Wolf Horrell, E. M., Boulanger, M. C., & D’Orazio, J. A. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00095 · Cited by 272
POMC: The Physiological Power of Hormone Processing
Harno, E., Gali Ramamoorthy, T., Coll, A. P., & White, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00024.2017 · Cited by 262
Metadata
- Authors
- Yang, Y.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 660
- Issue
- 1
- Pages
- 125-130
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2150327763
- Cited by
- 139
- References
- 4
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.